Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

VG Life Sciences, Inc. Release: New Data Implicate Components Of Adaptive Immunity In Traumatic Brain Injury

October 20, 2014 – 5:00 am | Edit Post

SANTA BARBARA, Calif., Oct. 20, 2014 (GLOBE NEWSWIRE) — VG Life Sciences Inc., (OTCQB:VGLS) a biotechnology company, announces today that one of its scientific advisors, Dr. Richard Tobin, PhD, published data demonstrating that when there is traumatic brain injury (TBI), the body inflicts additional…

Genervon Announces ALS And PD Phase 2a Trial Results

October 20, 2014 – 5:00 am | Edit Post

PASADENA, Calif.–(BUSINESS WIRE)–Genervon Biopharmaceuticals LLC (Genervon) today announced that it has completed the analysis of its Phase 2a double blinded, randomized, placebo controlled clinical trials of Amyotrophic Lateral Sclerosis (ALS)(NCT01854294) and Parkinsons disease (PD)(NCT 01850381) for its drug candidate GM6 (also known as GM604 in the ALS trial and GM608 in the PD trial…

AnaptysBio, Inc. Appoints To Newly Created Chief Development Officer Position Clinical Immunologist To Lead s Pipeline Advancement

October 20, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 20, 2014 /PRNewswire/ –AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies, today announced the appointment of Marco Londei, M.D. as Chief Development Officer. Dr. Londei will lead the preclinical and clinical development of AnaptysBio…

Personalis Introduces New Services For Cancer Research And Clinical Trials

October 20, 2014 – 5:00 am | Edit Post

Personalis, Inc., a leading genomics-based service provider, today announced it is launching an expanded portfolio of cancer research solutions based on its ACE (Accuracy and Content Enhanced) sequencing, informatics and content technology platform. Scientists from Personalis presented the new portfolio of cancer research solutions this weekend to attendees at the 2014 American Society of Human Genetics…

BioNano Genomics Announces One Human : One Chip : One Day

October 20, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 20, 2014 /PRNewswire/ –BioNano Genomics announced today achievement of a major milestone for the Irys system: the ability to collect human data at 30X depth, sufficient for a genome map, in 24 hours on a single chip…

Epic Sciences Appoints As Chief Information Officer

October 20, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 20, 2014 /PRNewswire/ –Epic Sciences announced today the appointment of Michael Giskeas chief information officer. Mr. Giske has more than 25 years of defining, designing and implementing…

Pathway Genomics Corporation Launches Patient Mobile App At American Society of Human Genetics 2014

October 20, 2014 – 5:00 am | Edit Post

Pathway Genomics Corporation, a CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, announced it has released a patient app that allows existing patients to view their genetic results on mobile devices, such as smart phones and tablets. The announcement was made at the 64th Annual Meeting of the American Society of Human Genetics (ASHG) in San Diego, California…

Cypher Genomics Identifies And Verifies Genetic Cause Of Rare Disease, Epileptic Encephalopathy

October 20, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 20, 2014 /PRNewswire/ –Cypher Genomics, Inc., the genome informatics company, announced today the identification of de novoKCNB1 missense mutations as a novel genetic cause of severe epileptic encephalopathy…

Ebola Clinical Trials: Big Name Players In The Ebola Race

October 20, 2014 – 5:00 am | Edit Post

FDA Approves DexCom SHARE???, The First Remote Mobile Communications Device Used For CGM

October 20, 2014 – 5:00 am | Edit Post

Now critical glucose data from the Dexcom G4 PLATINUM Continuous Glucose Monitoring System can be remotely monitored using a mobile deviceSAN DIEGO–(BUSINESS WIRE)–Dexcom, Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its CGM remote mobile…